GIPR and Alzheimer disease: It has been demonstrated that activation of GIPR showed potential therapeutic effects in animal models for both Alzheimer’s disease (AD) (16) and Parkinson’s disease (PD) (17), which was closely related to reducing chronic inflammation response in the brain.